<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28249697</identifier>
<setSpec>1578-1968</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Arce Arce, S</dc:author>
<dc:author>Sanjuán Rodríguez, L</dc:author>
<dc:author>León Ruiz, M</dc:author>
<dc:author>Pérez Nieves, M T</dc:author>
<dc:author>Ibáñez Estéllez, F</dc:author>
<dc:author>Rodríguez Sarasa, M L</dc:author>
<dc:author>García-Albea Ristol, E</dc:author>
<dc:author>Benito-León, J</dc:author>
<dc:description xml:lang="en">INTRODUCTION Very little has been written on seizure management in palliative care (PC). Given this situation, and considering the forthcoming setting up of the Palliative Care Unit at our neurorehabilitation centre, the Clínica San Vicente, we decided to establish a series of guidelines on the use of antiepileptic drugs (AEDs) for handling seizures in PC. METHODS We conducted a literature search in PubMed to identify articles, recent manuals, and clinical practice guidelines on seizure management in PC published by the most relevant scientific societies. RESULTS Clinical practice guidelines are essential to identify patients eligible for PC, manage seizures adequately, and avoid unnecessary distress to these patients and their families. Given the profile of these patients, we recommend choosing AEDs with a low interaction potential and which can be administered by the parenteral route, preferably intravenously. Diazepam and midazolam appear to be the most suitable AEDs during the acute phase whereas levetiracetam, valproic acid, and lacosamide are recommended for refractory cases and long-term treatment. CONCLUSIONS These guidelines provide general recommendations that must be adapted to each particular clinical case. Nevertheless, we will require further well-designed randomised controlled clinical trials including large samples of patients eligible for PC to draft a consensus document recommending adequate, rational, and effective use of AEDs, based on a high level of evidence, in this highly complex area of medical care.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Antiepileptic drug</dc:subject>
<dc:subject>Epilepsia</dc:subject>
<dc:subject>Cuidados paliativos</dc:subject>
<dc:subject>Fármaco antiepiléptico</dc:subject>
<dc:subject>Epilepsy</dc:subject>
<dc:subject>Palliative care</dc:subject>
<dc:subject>Terminal illness</dc:subject>
<dc:subject>Cáncer</dc:subject>
<dc:subject>Epileptic seizure</dc:subject>
<dc:subject>Crisis epiléptica</dc:subject>
<dc:subject>Situación de enfermedad terminal</dc:subject>
<dc:subject>Cancer</dc:subject>
<dc:date>2017 Feb 27 </dc:date>
<dc:title xml:lang="es">Guía para el manejo de las crisis epilépticas en cuidados paliativos: propuesta de un modelo actualizado de práctica clínica basado en una revisión sistemática de la literatura.</dc:title>
<dc:title xml:lang="en">Guidelines for seizure management in palliative care: Proposal for an updated clinical practice model based on a systematic literature review.</dc:title>
<dc:publisher>Neurologia (Barcelona, Spain)</dc:publisher>
</metadata>
</record>
</pubmed-document>
